WHO tracking new COVID-19 variant known as “mu”; tofacitinib safety study shows drug increases risk of heart-related events; mental health emergency facilities pop up around U.S.
The Vaccine Project Newsletter: Lessons learned the hard way
1 million COVID-19 booster shots already administered in U.S.; FDA to lose a pair of vaccine review officials by this fall; Johnson & Johnson HIV vaccine fails in mid-stage study.
Five things for health marketers to know: Tuesday, August 31, 2021
States begin rolling out digital vaccine passports; Biogen giving away controversial Alzheimer’s drug amid coverage uncertainty; Krispy Kreme ups the doughnut ante to get vaccinated.
Five things for health marketers to know: Monday, August 30, 2021
CDC calls on schools to implement stronger COVID-19 protocols; Biden administration attempts to track COVID-19 grants; FDA orders e-cigarette makers to pull products.
Why Pfizer/BioNTech should throw away the marketing playbook for Comirnaty
Vaccine makers should align around convincing the world to get more and more people vaccinated, even if it’s not their own vaccine, says one prominent ad exec.
Five things for health marketers to know: Friday, August 27, 2021
Rise in U.S. cases begins to slow; AstraZeneca’s Wilson disease drug successful in Phase III trial; Texas Gov. Greg Abbott reissues ban on COVID mandates.
The vax mandate era begins in long-term care facilities